How Insulin Works

Introduction
Insulin is one of the most researched hormones in physiology and medicine. Despite its centrality in health and disease, it is often oversimplified as merely “the sugar hormone.” In truth, insulin is a master regulatorKey controller of multiple metabolic processes of energy metabolismProcesses of nutrient use and storage that synchronizes nutrient storage and use across multiple tissues, integrates signals from dietNutrient intake patterns, exercisePhysical activity influencing metabolism, and stressPhysiological strain altering hormones, and influences not just glucose but also lipidFat molecules such as triglycerides, proteinAmino acid–based macromolecules, and vascular biologyFunction of blood vessels.

This article provides an in-depth exploration of insulin biology. It traces insulin’s path from pancreatic β-cell secretion to its rapid clearance in the liver and kidneys, explains how it signals through the insulin receptorMembrane receptor initiating insulin signaling, and details how it coordinates the activities of liverOrgan regulating glucose production and storage, muscleSkeletal tissue for glucose disposal, adipose tissueFat tissue for storage and hormone release, endotheliumCell lining of blood vessels, and the brainCentral nervous system tissue. It also examines insulin resistanceReduced tissue responsiveness to insulin, exercise physiology, and clinical misconceptions.


Index
Pancreatic β-Cell Function
Insulin in the Bloodstream and Clearance
Insulin Receptor and Signal Transduction
Insulin in the Liver
Insulin in Skeletal Muscle
Insulin in Adipose Tissue
Insulin and the Endothelium
Insulin and the Brain
Insulin Resistance Mechanisms
Exercise and Insulin-Independent Uptake
Integration of Fed and Fasted States
Common Misconceptions
Conclusion

Pancreatic β-Cell Function

Biosynthesis
Insulin is produced in pancreatic β-cells through a tightly coordinated pathway that safeguards folding, stability, and bioactivity. Translation begins as preproinsulinInsulin precursor with signal peptide on ribosomes bound to the rough endoplasmic reticulumOrganelle with ribosomes; protein folding site; its N-terminal signal peptide is removed to yield proinsulinSingle-chain insulin precursor. Inside the ER, chaperone systemsProteins that aid folding guide formation of three disulfide bondsS–S links stabilizing insulin chains. Properly folded proinsulin is trafficked to the Golgi apparatusOrganelle for modification and packaging and packaged into secretory granulesVesicles storing hormones.

Within these granules, proinsulin is processed by PC1/3Prohormone convertase enzyme and PC2Prohormone convertase enzyme, generating insulinPeptide hormone lowering blood glucose and C-peptideByproduct of proinsulin cleavage. Zinc ionsStabilize insulin hexamers promote insulin hexamerSix-insulin storage form assembly, creating dense-core granulesElectron-dense insulin storage vesicles. As glucose metabolism rises, these fuse with the plasma membraneCell surface membrane, releasing insulin and C-peptide. PMCID: PMC7966131

Stimulus-Secretion Coupling
Glucose uptake into β-cells is mediated by GLUT1Glucose transporter 1 and GLUT3Glucose transporter 3. Once inside, metabolism raises the ATP/ADP ratioEnergy charge of the cell, closing KATP channelsATP-sensitive K⁺ channels and causing depolarizationReduction of membrane potential.

This opens voltage-gated Ca²⁺ channelsCalcium entry channels, elevating intracellular Ca²⁺. Ca²⁺ triggers exocytosisVesicle fusion releasing contents. This cascade defines stimulus–secretion couplingMechanism linking glucose to insulin release. PMID: 7593639 PMID: 38775784 PMID: 10491749

Biphasic Secretion
With rising glucose, β-cells show a first phaseRapid burst from docked vesicles of insulin release from docked and primed granulesVesicles ready to fuse. The second phaseSustained release from reserves requires reserve poolsGranules deeper in cytoplasm and primingPreparation for release. Loss of the first-phase is an early defect in type 2 diabetes mellitusChronic metabolic disease. PMCID: PMC7966131

Amplification by Incretins
The hormones GLP-1Glucagon-like peptide-1 and GIPGlucose-dependent insulinotropic polypeptide are secreted by enteroendocrine cellsGut hormone-producing cells. They act on G protein–coupled receptorsSeven-helix signaling receptors to increase cAMPSecond messenger molecule. cAMP signals through protein kinase AcAMP-activated kinase and Epac2cAMP exchange protein, enhancing exocytotic competenceReadiness for release. This is the incretin effectOral glucose → greater insulin response.

Insulin in the Bloodstream and Clearance
Insulin circulates in the bloodstream for only a brief period, with a plasma half-life of approximately 3–10 minutesTime required for insulin concentration to fall by half. This rapid clearance reflects the body’s need to fine-tune insulin action in response to changing nutrient states. The liverPrimary site of first-pass insulin clearance plays the dominant role in this process: during first passInitial transit through the liver via the portal vein after secretion into the portal veinBlood vessel from pancreas/intestine to liver, hepatocytesLiver cells that degrade insulin extract and degrade a large fraction before it reaches the systemic circulationBlood circulation after liver clearance. Beyond the liver, the kidneysOrgans filtering and degrading insulin remove insulin via proximal tubule cellsKidney cells that reabsorb and break down peptides.

Because of this fast turnover, circulating insulin levels fluctuate quickly, and isolated plasma measurements may not accurately reflect β-cell activity. In contrast, C-peptideCleavage product of proinsulin, longer-lived, released in equimolar amounts with insulin, has a half-life of about 30 minutesApproximate plasma half-life of C-peptide. Unlike insulin, C-peptide is not subject to hepatic extraction, and its renal clearanceExcretion by the kidneys is slower and more predictable. For these reasons, C-peptide levels are widely used as a reliable marker of endogenous insulin secretion and β-cell output. PMID: 30968756 PMCID: PMC5446389

Back to Index

Insulin Receptor and Signal Transduction
The insulin receptorMembrane receptor that binds insulin is a heterotetrameric complexFour-subunit protein complex composed of two extracellular α-subunitsLigand-binding subunits and two transmembrane β-subunitsCatalytic kinase subunits, linked by disulfide bondsCovalent S–S links. It belongs to the family of receptor tyrosine kinasesLigand-activated protein kinases. When circulating insulin binds to the α-subunits, it induces a conformational changeShape shift that activates the receptor that turns on the tyrosine kinase activityEnzymatic addition of phosphate to tyrosines of the β-subunits. This triggers autophosphorylationReceptor phosphorylates itself on specific tyrosines, creating docking sites for insulin receptor substrates (IRS)Adaptor proteins that relay the signal.

Phosphorylated IRS proteins then engage parallel pathways. The most prominent is the PI3K–Akt pathwayMetabolic signaling route, which drives glucose handling and storage. AktSer/Thr kinase downstream of PI3K promotes glucose uptake via GLUT4 translocationMoving transporters to the surface, stimulates glycogen formation by inhibiting glycogen synthase kinase 3 (GSK3)Kinase that suppresses glycogen synthase, and supports lipid storage by upregulating enzymes of lipogenesisFat synthesis. In parallel, the receptor also signals through the MAPK pathwayMitogen-activated protein kinase route, which regulates gene expression programs linked to cell growth, differentiation, and survival.

This dual architecture lets insulin couple rapid metabolic control with longer-term transcriptional responses, coordinating nutrient use with tissue adaptation. PMID: 11742412

Back to Index

Insulin in the Liver
In the liverOrgan regulating glucose and lipid metabolism, insulin exerts its strongest effects by balancing glucose production and storage. During fasting, hepatocytesLiver cells maintain blood glucose through gluconeogenesisNew glucose production from precursors and glycogenolysisBreakdown of glycogen to glucose. After meals, insulin suppresses these pathways. A central mechanism involves AktProtein kinase downstream of PI3K, which phosphorylates FoxO1Transcription factor regulating gluconeogenic genes. Once phosphorylated, FoxO1 exits the nucleus, preventing expression of enzymes such as PEPCKPhosphoenolpyruvate carboxykinase and G6PaseGlucose-6-phosphatase, shutting down hepatic glucose output.

Simultaneously, insulin promotes storage. By activating glycogen synthaseEnzyme building glycogen chains—via Akt-mediated inhibition of GSK3—it enhances glycogen synthesisFormation of glycogen from glucose. Insulin also induces fat storage programs by activating transcription factors like SREBP-1cSterol regulatory element–binding protein and ChREBPCarbohydrate response element–binding protein, boosting lipogenesisSynthesis of fatty acids and triglycerides.

By curbing glucose output and promoting glycogen and lipid storage, insulin makes the liver a central hub for maintaining post-meal glucose and energy balance. PMID: 17088248

Back to Index

Insulin in Skeletal Muscle
In skeletal muscleVoluntary muscle tissue; major glucose sink, insulin plays a key role in nutrient uptake and anabolic metabolism. A central action is increasing GLUT4 traffickingMovement of GLUT4 glucose transporters to membrane. Without insulin, most GLUT4 remains in vesicles. Upon insulin stimulation, IRS–PI3K–Akt and effectors such as AS160/TBC1D4Rab-GTPase regulator controlling GLUT4 vesicles mobilize GLUT4 to the surface, enabling glucose uptakeTransport of glucose into cells.

Insulin also enhances storage. It activates glycogen synthaseEnzyme forming glycogen chains indirectly by inhibiting glycogen synthase kinase 3 (GSK3)Enzyme that blocks glycogen synthase, ensuring efficient glycogen formation. In parallel, insulin stimulates protein synthesisBuilding new proteins from amino acids via the mTORC1 pathwayNutrient-sensing complex promoting growth, driving ribosome activity and translation.

Insulin also modulates blood flow. By activating PI3K–Akt–eNOSEndothelial nitric oxide synthase signaling in vascular cells, insulin raises nitric oxide (NO)Gaseous vasodilator, causing capillary recruitmentOpening of more perfused capillaries. This increases nutrient delivery to muscle fibers. Collectively, these metabolic and vascular effects make insulin indispensable for skeletal muscle energy balance and growth. PMCID: PMC2493596

Back to Index

Insulin in Adipose Tissue
In adipose tissueFat tissue storing energy and releasing hormones, insulin acts as a powerful antilipolytic hormoneHormone that suppresses fat breakdown, ensuring circulating fuels are controlled after meals. During fasting, triglycerides in fat cells are broken down by lipases including adipose triglyceride lipase (ATGL)Enzyme initiating triglyceride breakdown and hormone-sensitive lipase (HSL)Enzyme releasing fatty acids from triglycerides. Their activity depends on phosphorylation by protein kinase A (PKA)cAMP-activated kinase, which is stimulated when cAMPSecond messenger regulating enzymes levels are high.

Insulin blocks this cascade via the PI3K–Akt pathwayInsulin signaling route to metabolism, which activates PDE3BPhosphodiesterase degrading cAMP. PDE3B hydrolyzes cAMP to AMP, lowering PKA activity. With less phosphorylation, ATGL and HSL remain less active, suppressing triglyceride breakdown. This limits release of non-esterified fatty acids (NEFAs)Free fatty acids circulating in blood into plasma.

By restraining lipolysis, insulin ensures dietary carbohydrate is prioritized for energy and storage. When insulin action fails, as in insulin resistanceReduced tissue response to insulin, lipolysis accelerates, elevating plasma NEFAs that drive fat deposition in liver and muscle, worsening metabolic dysfunction. PMID: 31109317

Back to Index

Insulin and the Endothelium
In the endotheliumCell layer lining blood vessels, insulin regulates vascular function beyond metabolism. Binding to endothelial insulin receptors activates the PI3K–Akt pathwaySignal cascade enhancing vasodilation, which phosphorylates endothelial nitric oxide synthase (eNOS)Enzyme producing nitric oxide in vessels. Activated eNOS generates nitric oxide (NO)Gas that relaxes blood vessels, promoting vasodilationWidening of blood vessels and increased flow.

A major outcome is microvascular recruitmentOpening of previously closed capillaries. This expands the exchange surface for glucose and hormones, improving delivery to muscle fibers.

In insulin resistanceImpaired tissue response to insulin (e.g., obesity, type 2 diabetes), this vascular branch is impaired. While the MAPK armSignaling branch tied to growth and vasoconstriction often stays intact—promoting endothelin-1Vasoconstrictor peptide—the PI3K–Akt–eNOS branch weakens. This imbalance reduces NO, blunts vasodilation, and worsens glucose disposal, fueling systemic resistance. PMID: 19283361 PMID: 15161743

Back to Index

Insulin and the Brain
In the brainCentral nervous system; regulates cognition and metabolism, insulin functions as a neuromodulator beyond glucose control. Circulating insulin crosses the blood–brain barrierSelective barrier regulating brain access via a receptor-mediated transport system. Inside the CNS, insulin acts in the hypothalamusBrain region controlling appetite and energy balance, a key metabolic hub.

Here, insulin binds neuronal receptors and activates pathways that suppress appetite by reducing orexigenic neuropeptidesAppetite-stimulating signals while enhancing anorexigenic pathwaysAppetite-suppressing signals. Insulin also lowers sympathetic nervous system outputStress/fight-or-flight branch of the nervous system to adipose tissue, reducing lipolysis and limiting fatty acid release.

When brain insulin signaling falters—known as central insulin resistanceBrain’s reduced responsiveness to insulin—appetite suppression weakens, sympathetic drive stays high, and fat breakdown increases, worsening systemic metabolism. This dysfunction links insulin to obesityExcessive body fat accumulation and type 2 diabetesMetabolic disease with insulin resistance, and has been implicated in cognitive decline and dementia. PMID: 21540447

Back to Index

Insulin Resistance Mechanisms
At the cellular levelProcesses occurring within cells, insulin resistance emerges from lipid buildup, signaling defects, and impaired blood flow. A key mechanism is accumulation of diacylglycerol (DAG)Lipid intermediate activating kinases under nutrient excess. In the liverCentral organ for glucose and fat metabolism, DAG activates PKCεProtein kinase C epsilon isoform, which phosphorylates the insulin receptor on inhibitory sites, disrupting signaling. In skeletal muscleVoluntary muscle; major glucose consumer, PKCθProtein kinase C theta isoform causes similar defects, blunting IRS–PI3K–Akt signaling. These lipid–kinase links explain obesity-driven insulin resistance. PMID: 27760050 PMCID: PMC7544641 PMCID: PMC4084449

Another lipid, ceramideSphingolipid that impairs signaling, blocks Akt activationTurning on Akt kinase in insulin signaling. Ceramides trap Akt in inactive complexes or promote phosphatases that undo phosphorylation, reducing GLUT4 movement and weakening liver glucose suppression.

Chronic overnutrition also activates mTORC1Nutrient-sensing growth complex, whose effector S6KRibosomal protein S6 kinase phosphorylates IRS proteins on serine sites, diminishing their signaling capacity. Thus nutrient surplus feeds back to blunt insulin action. PMID: 17611409

Vascular supply also matters. Normally, insulin stimulates microvascular recruitmentOpening of capillaries to improve delivery, increasing glucose/insulin access to muscle. In obesity, this is impaired, limiting delivery regardless of signaling.

Finally, adipose tissue insulin resistanceFat cells less responsive to insulin amplifies dysfunction. Lipolysis persists, releasing excess non-esterified fatty acids (NEFAs)Free fatty acids in blood, fueling further DAG/ceramide buildup and reinforcing resistance.

Overall, insulin resistance stems from lipid overload, faulty signaling, vascular defects, and adipose dysfunction acting together.

Back to Index

Exercise and Insulin-Independent Uptake
Skeletal muscleVoluntary muscle; primary site of glucose disposal can take up glucose in response to contractionsMuscle fiber shortening during activity, even without insulin. This uses signaling distinct from the insulin receptor. During exercise, contractions raise intracellular calcium and activate AMP-activated protein kinase (AMPK)Energy sensor kinase triggered by low ATP. Calcium and AMPK converge on trafficking machinery that mobilizes GLUT4 glucose transportersProteins moving glucose into cells to the membrane.

This resembles insulin’s GLUT4 effect but bypasses IRS–PI3K–Akt. Crucially, because contraction signaling stays intact in insulin resistanceState where tissues respond poorly to insulin, exercise restores glucose uptake when insulin action is blunted. A single bout improves muscle glucose disposal, while training enhances mitochondria, glycogen, and insulin sensitivity long-term.

Exercise also increases metabolic flexibility—boosting both glucose uptake and fatty acid oxidation—reducing lipid buildup that drives resistance. These adaptations explain why regular activity is a foundational therapyCore treatment approach for type 2 diabetes and metabolic syndrome. PMID: 23899560 PMCID: PMC4209358

Back to Index

Integration of Fed and Fasted States

State	Liver	Muscle	Adipose	Endothelium
Fasted	Glucose output, gluconeogenesisMaking glucose from non-carbohydrate sources	Oxidizes fatty acids	LipolysisBreakdown of stored fat active	Baseline tone
Fed	Suppresses output, stores glycogenStored form of glucose, lipogenesisConversion of glucose into fat	GLUT4Insulin-regulated glucose transporter uptake, glycogen and protein synthesis	Suppresses lipolysis, stores TGTriglycerides; stored fat	VasodilationWidening of blood vessels, capillary recruitmentOpening more small vessels for exchange

Back to Index

Common Misconceptions

“Insulin just pushes sugar into cells.”
Insulin does far more, coordinating nutrient partitioning, vascular delivery, protein synthesis, and
lipogenesisProcess of converting carbohydrates into fat.

“Insulin spikes alone cause fat gain.”
Net fat gain requires caloric surplus. Insulin partitions energy but does not override energy balance.
PMID: 22215165

“Broken metabolism explains obesity.”
Metabolic rate differences exist but are bounded. True pathological exceptions include
lipoedemaAbnormal fat distribution disorder or
lipodystrophyCondition with abnormal loss of fat tissue.

Back to Index

Conclusion
Insulin is the master regulator of nutrient use and storage. Its influence spans from β-cell stimulus–secretion couplingProcess linking glucose metabolism to insulin release to its brief circulation and clearance by the liverPrimary organ clearing insulin and kidneysSecondary organ degrading insulin. Once bound to its receptor, insulin orchestrates multiple organs—suppressing hepatic glucose output, enhancing muscle uptake, limiting adipose lipolysisFat breakdown, and influencing vascular tone and appetite regulation.

The development of insulin resistanceReduced tissue responsiveness to insulin reflects not one defect but a network: lipid intermediates like diacylglycerolsLipids that activate inhibitory kinases and ceramidesLipids that block Akt signaling, chronic activation of mTORC1–S6KNutrient-sensing pathway that inhibits insulin signaling, vascular impairment, and loss of adipose suppression. Together, these fuel systemic dysfunction.

Yet insulin sensitivity can be restored. Structured exercisePhysical activity that enhances glucose uptake, balanced dietNutritional pattern supporting metabolic health, and reduced overload improve responsiveness. Contraction-mediated GLUT4 translocation bypasses defects, vascular adaptations improve delivery, and less nutrient stress relieves inhibition. This shows insulin networks retain plasticity, highlighting the power of lifestyle and clinical strategies to restore balance.

Back to Index

Classroom Group Discussion: Exploring Insulin Biology and Its Clinical Implications

Objective
The goal is to help students analyze insulin biology at molecular, physiological, and clinical levels. This includes questions, proposed experiments, and patient-centered conversations that connect science to practice.

Discussion Questions
Students begin by engaging with questions such as:

- How do glucose transporters (GLUT1Facilitative glucose transporter; widely expressed,
GLUT2Low-affinity glucose transporter in liver & pancreas,
GLUT4Insulin-regulated glucose transporter in muscle & fat) differ across tissues, and why?

- Why is the biphasic pattern of insulin secretion clinically important, especially in early type 2 diabetesMetabolic disorder with insulin resistance?

- How does exercisePhysical activity that enhances glucose uptake bypass insulin resistance, and what therapeutic strategies arise from this?

- Insulin resistance involves lipids (DAGDiacylglycerol; lipid signaling molecule,
ceramidesLipids that impair insulin signaling), inflammation, and vascular dysfunction. Which is most feasible to target clinically?

- From a systems perspective, how might brain insulin resistance contribute to obesityExcessive fat accumulation and cognitive decline?

Proposed Laboratory Experiments

- In vitro β-cell culture experiment: Expose pancreatic β-cells to varying glucose ± GLP-1Incretin hormone enhancing insulin secretion, then measure insulin release.

- Muscle strip contraction model: Use rodent muscle samples to show insulin-independent GLUT4 translocationMovement of glucose transporters to membrane.

- Western blot analysis: Compare Akt phosphorylationActivation step in insulin signaling in cells treated with insulin under normal vs lipid-rich conditions.

- In vivo tracer study: Discuss isotope-labeled glucose infusions for measuring hepatic glucose output and uptake.

Patient-Centered Conversations

- How to explain that weight gain is not just due to “insulin spikes” but overall caloric balance?
- What strategies (diet, exercise, medications) improve sensitivity in type 2 diabetes?
- How to reduce stigma for patients with lower metabolic rates or strong genetic predisposition?
- How can cultural and socioeconomic factors shape lifestyle interventions?

Interactive Group Activity
Groups receive patient profiles (e.g., a sedentary man with visceral obesity, a woman with PCOSPolycystic ovary syndrome; linked to insulin resistance, or an older adult at dementia risk). Each group discusses:

- Likely mechanisms of insulin resistance.
- Possible lab tests (fasting insulin, C-peptideByproduct of insulin production; marker of secretion, oral glucose tolerance test).
- A 3-part plan: lifestyle, pharmacologic, educational.

Groups present and compare strategies.

Closing Reflection
The session concludes by showing insulin as more than a hormone—it’s a framework for understanding systemic disease and guiding patient care. Students reflect on how insulin links cellular signaling, organ physiology, and human experience, emphasizing its role in metabolic health.